Importantly, these medications carry a boxed warning about thyroid C-cell tumors observed in rodent studies and are contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
IGFBP7 is not required for B-RAF-induced melanocyte senescence
Every detail, from the purity of the initial productsomething we obsess over at Real Peptidesto the final, gentle swirl of the vial, contributes to the scientific process
Notably, the drug resistance observed in animals treated with Exenatide was not seen in those treated with Exendin-4-Fc
A double-blind, randomized phase 2 study comparing various doses (1, 5, 10, 15 mg) of once weekly tirzepatide, dulaglutide (1.5 mg) and placebo, in patients with T2DM, showed tirzepatide was superior on weight loss and glucose-lowering compared to both dulaglutide and placebo [52]
Critically, no standardized, quantitative, or dynamic assays exist for monitoring ferroptotic or cuproptotic activity in clinical settings
.jpg)
